KennersonLaboratory

94 posts

KennersonLaboratory

KennersonLaboratory

@KennersonLab

The Northcott Neuroscience Laboratory is internationally renowned for molecular genetics of human heriditary neuropathies at the @anzacinstitute

Katılım Aralık 2019
81 Takip Edilen82 Takipçiler
KennersonLaboratory retweetledi
ern euro_nmd
ern euro_nmd@euro_nmd·
➡️Next #EURONMD webinar w/ @ERN_RND & @EANeurology. 📚"Pathomechanisms of Charcot-Marie-Tooth Disease" delivered by Dr. Stefano Carlo Previtali (IRCCS Ospedale San Raffaele, Italy) 📅Oct 4th, 2023 at 16:00 CEST ℹ️More information and registration here 👉bit.ly/3t2EIsY
ern euro_nmd tweet media
English
0
3
10
1.5K
KennersonLaboratory retweetledi
Brad Turner
Brad Turner@turnerMNDlab·
Fantastic session on #ALS models and mechanisms at #PACTALS23 #KualaLumpur! Excited to speak about the largest ALS patient stem cell library in Australia for disease profiling and drug screening established at @TheFlorey generously funded by @FightMND
Brad Turner tweet media
English
0
10
39
1.5K
KennersonLaboratory retweetledi
Ramesh Narayanan
Ramesh Narayanan@RMeshNarayanan·
Job listing for neurobiologists, stem cell biologists and mouse biologists as advertised on @WhovaSupport app at the recently concluded #ANS2022. Plenty of interesting opportunities from around Oz and one from Pittsburg uni (USA). Please RT!!
English
1
2
2
0
KennersonLaboratory retweetledi
CMT Research Foundation
CMT Research Foundation@CMTRF·
"Further research in repeat expansion and non-coding DNA may close the diagnostic gap in CMT" - Dr. Andrea Cortese
English
0
1
1
0
KennersonLaboratory retweetledi
Ramesh Narayanan
Ramesh Narayanan@RMeshNarayanan·
Amazing work!! More reasons to study RNA species bound and regulated by TDP-43 to understand its role in ALS and nervous system function.
M W@Michael_E_Ward_

New paper @Nature! With Pietro Fratta’s team @UCL, we uncovered a link between TDP-43 mis-localization and mis-splicing of UNC13A, a key synaptic gene, in ALS. Exemplifies power of human iPSC neuron models in predicting disease mechanisms + team science. nature.com/articles/s4158…

English
0
1
1
0
KennersonLaboratory retweetledi
Keith N. Fargo, PhD
Keith N. Fargo, PhD@KeithNFargo·
When is it time for your #biotech to look at CMT as an indication? When you are looking for a rare disease with high unmet medical need, but would also benefit from a potential market of 3M ppl globally, mature natural history studies, and an existing clinical trial network.
Rare Disease Report@RareDR

"It's our job to educate [people in #biotech] and help them understand why it would be beneficial for them, as well as for #CMT patients, for them to work in CMT" @KeithNFargo PhD, @CMTRF #RareDiseaseDay #CharcotMarieTooth #Genetherapy ow.ly/28r750I5Zvk

English
0
5
4
0
KennersonLaboratory retweetledi
Keith N. Fargo, PhD
Keith N. Fargo, PhD@KeithNFargo·
Read about why our CEO Susan Ruediger co-founded the @CMTRF, the progress we have made in three short years, and why the future is bright for CMT treatments and cures. ajc.com/life/radiotvta…
Keith N. Fargo, PhD tweet media
English
0
1
2
0
KennersonLaboratory retweetledi
Julius Rönkkö
Julius Rönkkö@julius_ronkko·
Excellent talks from a wide variety of perspectives to tackle CMT disease. Thank you for the presenters and organizers, learned a lot! Now, last session about Clinical trial readiness! #globalcmtresearchconvention
English
0
2
3
0

Keşfet

@ERN_RND @EANeurology @TheFlorey @FightMND @BrainMind_Usyd @SeoulNatlUni @Sicong_T @nervecentrals